Gallacher Capital Management »

Neurocrine Biosciences shares owned by Gallacher Capital Management

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Gallacher Capital Management from 13F filings

Historical chart of Gallacher Capital Management investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Gallacher Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Gallacher Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $232k 1.8k 131.74

More positions owned by Gallacher Capital Management

Pepsi (PEP)
Alps Etf Tr Smith Core Plus (SMTH)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Yum! Brands (YUM)
Ishares Tr S&p 500 Grwt Etf (IVW)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Msci Emrg Chn (EMXC)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Select Sector Spdr Tr State Street Tec (XLK)
Vanguard Index Fds Total Stk Mkt (VTI)
Apple (AAPL)
Ishares Tr Latn Amer 40 Etf (ILF)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Gallacher Capital Management

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
Dodge & Cox
AQR Capital Management
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Two Sigma Investments
Renaissance Technologies
Geode Capital Management
Wellington Management Company
Bellevue Group
Bnp Paribas Investment Partners
Vestal Point Capital
Millennium Management

View all funds holding Neurocrine Biosciences